AbBio is a biopharmaceutical company dedicated to developing next generation
R&D platforms and products for pharmaceutical applications.
- FRET-based assessment and optimization of drug formulation
- Sandwich and direct ELISA-based target validation and quantification
- Primary neuron culture-based evaluation of neurotoxic compounds
- Optimal solubilization and stabilization of therapeutic proteins and antibodies